Why RSV deserves attention before winter
Respiratory syncytial virus (RSV) often causes cold-like symptoms, but it can lead to pneumonia or hospitalization in older adults, especially people with heart or lung conditions, weakened immune systems or other risk factors. According to the CDC's RSV guidance for adults, risk generally increases with age.
In its October 16, 2026 respiratory-illness snapshot, CDC reported very low RSV activity in most areas of the country. That is a dated national snapshot, not a prediction for your community. CDC says late summer and early fall are generally good times for eligible adults to get vaccinated before seasonal spread increases.
Who should ask about an RSV vaccine?
Under the CDC recommendations available October 23, 2026:
- Everyone age 75 or older: CDC recommends one RSV vaccine dose if you have not received one before.
- Adults ages 50–74 at increased risk: CDC recommends one dose for those with qualifying medical conditions or other risk factors for severe RSV illness.
- Adults 50–74 without increased risk: The recommendation is not universal. Ask your healthcare professional whether your circumstances meet the risk-based criteria.
Examples of risk factors include chronic heart or lung disease, certain complicated forms of diabetes, moderate or severe immune compromise, severe obesity and nursing-home residence. Eligibility depends on the specific medical circumstances, so don't assume every person with diabetes or high blood pressure meets the criteria. Your clinician can review the full CDC list with you.
What will Medicare pay?
Medicare.gov states that Medicare Part D covers the RSV vaccine and that people with Part D pay $0 for the covered recommended vaccine—no Part D copayment or deductible. Medicare Advantage plans that include Part D drug coverage also provide this drug benefit.
This is a Part D benefit, not the standard Part B flu-shot benefit. If you receive drug coverage through a Medicare Advantage plan, confirm your plan's vaccination billing arrangements and where you can receive the shot. If you do not have Part D or have other coverage, ask the provider or pharmacy to verify your coverage and potential cost before vaccination.
Three questions to ask before your appointment
- Am I eligible? Tell your doctor or pharmacist your age, medical conditions and whether you have ever received an RSV vaccine.
- Where can I get it with my coverage? Ask your Part D plan or pharmacy how the vaccine is billed and whether the location can process the benefit.
- How should I coordinate other vaccines? Your healthcare professional can discuss timing with flu and other recommended vaccinations, your allergies and your medical history.
RSV vaccines may cause temporary side effects, such as soreness, fatigue or headache. Discuss your personal risks, contraindications and questions with a qualified healthcare professional. Seek urgent medical care for severe symptoms such as difficulty breathing or chest pain.
What does this mean for 2027 Medicare Open Enrollment?
The regular Medicare Annual Enrollment Period runs October 15–December 7, 2026, with most elections effective January 1, 2027. You do not need to change your plan just to receive a currently covered recommended RSV vaccine. However, your broader 2027 Part D or Medicare Advantage review should still include prescription coverage, pharmacy arrangements, premiums and estimated total costs. A vaccine benefit alone does not tell you whether a plan is the right fit.
If you are reviewing your 2027 Medicare Advantage or Part D options, Michael Johnson can help you compare coverage based on your medications, preferred pharmacy, healthcare needs and budget. Visit MedicareAdvisor4u.com and click Book a Medicare Review, or call 984-400-8451.